Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Most patients with dermatomyositis had skin rash, itching, and muscle weakness, treated mainly with prednisolone and hydroxychloroquine.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

Skin ulcers from interferon may not depend on the amount given.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

The oils showed potential to kill certain cancer cells, especially from Dysphania ambrosioides.

Lithium can cause skin changes similar to mycosis fungoides.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

Radiation therapy can worsen Discoid Lupus Erythematosus.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.